Patent · US Active

Methods of use for trisubstituted benzotriazole derivatives

US12290508B2 · kind B2 · utility

0Cited by
6References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 9, 2023
Grant dateMay 6, 2025
Priority date
Expiry dateJun 9, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods for treating cancer in a subject with a trisubstituted benzotriazole derivative with the formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.